mitomycin has been researched along with Anemia, Hemolytic in 23 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Excerpt | Relevance | Reference |
|---|---|---|
| "After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome." | 7.67 | Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. ( McCarthy, JT; Staats, BA, 1986) |
| "A thrombotic microangiopathy resembling the hemolytic uremic syndrome was diagnosed in 12 patients with adenocarcinoma, in whom the tumor was in complete or near-complete remission after treatment with mitomycin C-containing drug regimens." | 7.67 | Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. ( Cantrell, JE; Phillips, TM; Schein, PS, 1985) |
| "We examined various markers in 17 patients with thrombotic thrombocytopenic purpura (TTP), 13 with red cell fragmentation syndrome (RCFS) induced by mitomycin C, and 36 with RCFS caused by disseminated intravascular coagulation (DIC)." | 3.69 | [Plasma level of various markers in patients with thrombotic thrombocytopenic purpura]. ( Shirakawa, S; Tamaki, S; Wada, H, 1994) |
| "A 68-year-old man was treated with FAM (5-fluorouracil, doxorubicin [Adriamycin], mitomycin-C) for metastic gastric adenocarcinoma." | 3.67 | Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. ( Kerwin, DM; Smith, FP; Tsou, E; Waldhorn, RE, 1984) |
| "After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome." | 3.67 | Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. ( McCarthy, JT; Staats, BA, 1986) |
| "A thrombotic microangiopathy resembling the hemolytic uremic syndrome was diagnosed in 12 patients with adenocarcinoma, in whom the tumor was in complete or near-complete remission after treatment with mitomycin C-containing drug regimens." | 3.67 | Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. ( Cantrell, JE; Phillips, TM; Schein, PS, 1985) |
| "Following gastrectomy for locally advanced adenocarcinomas, three patients developed microangiopathic hemolytic anemia and renal failure shortly after completing courses of adjuvant chemotherapy with mitomycin and 5-FU." | 3.66 | Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. ( Band, PR; Bettez, P; Giroux, L; Gruber, J; Jolivet, J; Laurin, S, 1983) |
| "Although fatigue was the most frequently encountered toxicity safety profiles were generally predictable and manageable." | 2.73 | Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study. ( Cho, EK; Chung, M; Hong, J; Kim, YS; Lee, JH; Lee, WK; Nam, E; Park, J; Park, SH; Shin, DB, 2008) |
| "The patient was first diagnosed with squamous cell carcinoma of the anus 1 year before admission." | 1.32 | Cases from the Osler Medical Service at Johns Hopkins University. ( Brown, C; Zetola-Burneo, N, 2004) |
| "A case of advanced gastric cancer associated with metastatic carcinomatosis of the bone marrow, microangiopathic hemolytic anemia (MAHA) and disseminated intravascular coagulation (DIC) was reported." | 1.27 | [Microangiopathic hemolytic anemia associated with gastric cancer]. ( Hattori, T; Kanou, T; Kuramoto, J; Miura, K; Niimoto, M; Nosou, Y; Yanagawa, E; Yoshinaka, K, 1986) |
| "The mitomycin C dose was less than or equal to 15 mg/m2 every 53rd day and the total cumulative dose was between 25 and 250 mg." | 1.27 | Renal complications of mitomycin C therapy with special reference to the total dose. ( Nordman, E; Valavaara, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (69.57) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SH | 1 |
| Kim, YS | 1 |
| Hong, J | 1 |
| Park, J | 1 |
| Nam, E | 1 |
| Cho, EK | 1 |
| Shin, DB | 1 |
| Lee, JH | 1 |
| Lee, WK | 1 |
| Chung, M | 1 |
| Wen, MC | 1 |
| Chen, CH | 1 |
| Ho, WL | 1 |
| Zetola-Burneo, N | 1 |
| Brown, C | 1 |
| Jolivet, J | 1 |
| Giroux, L | 1 |
| Laurin, S | 1 |
| Gruber, J | 1 |
| Bettez, P | 1 |
| Band, PR | 1 |
| Perry, DJ | 1 |
| Doll, DC | 1 |
| Weiss, RB | 1 |
| Ravikumar, TS | 1 |
| Sibley, R | 1 |
| Reed, K | 1 |
| Grage, TB | 1 |
| Waldhorn, RE | 1 |
| Tsou, E | 1 |
| Smith, FP | 1 |
| Kerwin, DM | 1 |
| Ito, S | 1 |
| Hirono, S | 1 |
| Kobayashi, M | 1 |
| Wada, H | 2 |
| Wakita, Y | 1 |
| Shimura, M | 1 |
| Nakase, T | 1 |
| Hiyoyama, K | 1 |
| Nagaya, S | 1 |
| Minami, N | 1 |
| Nakano, T | 1 |
| Shiku, H | 1 |
| Tamaki, S | 1 |
| Shirakawa, S | 1 |
| Godes, M | 1 |
| Camps, C | 1 |
| MartÃnez, A | 1 |
| Mackintosh, J | 1 |
| Sagawa, M | 1 |
| Sakuma, T | 1 |
| Takahashi, S | 1 |
| Usuda, K | 1 |
| Satoh, M | 1 |
| Kamma, K | 1 |
| Ohta, S | 1 |
| Nagamoto, N | 1 |
| Imai, T | 1 |
| Saitoh, Y | 1 |
| McCarthy, JT | 1 |
| Staats, BA | 1 |
| Kanou, T | 1 |
| Nosou, Y | 1 |
| Yoshinaka, K | 1 |
| Yanagawa, E | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
| Miura, K | 1 |
| Kuramoto, J | 1 |
| Claycomb, CL | 1 |
| Berkovic, M | 1 |
| Hostetter, AL | 1 |
| Tubbs, RR | 1 |
| Ziegler, T | 1 |
| Gephardt, GN | 1 |
| McMahon, JT | 1 |
| Schreiber, MJ | 1 |
| Yasunaga, C | 1 |
| Komota, T | 1 |
| Mimura, K | 1 |
| Kinjyo, M | 1 |
| Sueishi, K | 1 |
| Hirose, T | 1 |
| Hayano, K | 1 |
| Fukui, H | 1 |
| Otsuka, Y | 1 |
| Hattori, S | 1 |
| Valavaara, R | 1 |
| Nordman, E | 1 |
| Price, TM | 1 |
| Murgo, AJ | 1 |
| Keveney, JJ | 1 |
| Miller-Hardy, D | 1 |
| Kasprisin, DO | 1 |
| Cantrell, JE | 1 |
| Phillips, TM | 1 |
| Schein, PS | 1 |
1 review available for mitomycin and Anemia, Hemolytic
| Article | Year |
|---|---|
Chemotherapeutic agents and the erythron.
Topics: Anemia, Hemolytic; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Erythrocyte Membra | 1983 |
1 trial available for mitomycin and Anemia, Hemolytic
| Article | Year |
|---|---|
Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study.
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; | 2008 |
21 other studies available for mitomycin and Anemia, Hemolytic
| Article | Year |
|---|---|
Mitomycin C-induced renal insufficiency: a case report.
Topics: Anemia, Hemolytic; Antibiotics, Antineoplastic; Humans; Hypertension; Kidney Diseases; Male; Middle | 2003 |
Cases from the Osler Medical Service at Johns Hopkins University.
Topics: Anemia, Hemolytic; Antibiotics, Antineoplastic; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Hu | 2004 |
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Topics: Adenocarcinoma; Adult; Anemia, Hemolytic; Drug Therapy, Combination; Female; Fluorouracil; Humans; K | 1983 |
Reversible microangiopathic hemolytic anemia after mitomycin C.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antibiotics, Antineoplastic; Humans; Male; Mitomycin; Mitom | 1983 |
Renal toxicity of mitomycin-C.
Topics: Adult; Aged; Anemia, Hemolytic; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; K | 1984 |
Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin | 1984 |
[Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Agents; Aspirin; Chromomycin A3; Dipyridamole; Female | 1982 |
Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Combined Modality Therapy; Disseminat | 1995 |
[Plasma level of various markers in patients with thrombotic thrombocytopenic purpura].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Biomarkers; Blood Coagulation Factors | 1994 |
[Microangiopathic hemolytic anemia associated with mitomycin-C treatment].
Topics: Acute Kidney Injury; Anemia, Hemolytic; Humans; Male; Middle Aged; Mitomycin | 1991 |
Cardiopulmonary complications of mitomycin-C.
Topics: Anemia, Hemolytic; Female; Heart Failure; Humans; Hypertension, Pulmonary; Middle Aged; Mitomycin; M | 1990 |
[Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
Topics: Acute Kidney Injury; Aged; Anemia, Hemolytic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 1987 |
Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
Topics: Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Colonic N | 1986 |
[Microangiopathic hemolytic anemia associated with gastric cancer].
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Benzodiazep | 1986 |
Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
Topics: Adenocarcinoma; Anemia, Hemolytic; Colonic Neoplasms; Female; Fluorouracil; Humans; Kidney Failure, | 1986 |
Chronic glomerular microangiopathy complicating metastatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anemia, Hemolytic; Blood Coagulation; Chronic Disease; Female; Hemolyti | 1987 |
[Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
Topics: Adenocarcinoma; Anemia, Hemolytic; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Postoperative C | 1987 |
[Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Breast Neoplasms; Female; Fluorouracil; Glomerulonephritis, | 1988 |
Renal complications of mitomycin C therapy with special reference to the total dose.
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Female; | 1985 |
Renal failure and hemolytic anemia associated with mitomycin C. A case report.
Topics: Anemia, Hemolytic; Biopsy; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mitomycin; Mitomycins | 1985 |
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Anemia, Hemolytic; Antibiotics, Antineoplastic; Antigen- | 1985 |